Gordon Campbell On Funding New Drugs, And Governing In Bad Faith

Like the arms race, the funding of new cancer drugs is an endless upwards spiral. First though, let’s have the good news. Yesterday, the Phamac office in Wellington announced that from October 1st, the expensive cancer drug Keytruda will be made available to eligible people with advanced triple-negative breast cancer, head and neck cancer, colorectal cancer, bladder cancer, and Hodgkin lymphoma.